2006

EllowayEAG, Bird RA, Hewitt CJ, Kelly SL, Smith SN. Characterization of Acanthamoeba-microsphere association by multiparameter flow cytometry and confocal microscopy. Cytometry Part A 2006, 69A (4): 266-272.

Kaderbhai MA, Kelly SL, Kaderbhai, NN. Towards engineered topogenesis of cytochrome b5 and P450 for in vivo transformation of xenobiotics. Biochemical Society Transactions 2006, 34(6) 1231-1235 .

Kelly SL, Lamb DC, Kelly DE. Cytochrome P450 biodiversity and biotechnology. Biochemical Society Transactions 2006, 34(6) 1159-60.

Lamb DC, Guengerich FP, Kelly SL, Waterman, MR. Exploiting Streptomyces coelicolor A3(2) P450s as a model for application in drug discovery. Expert Opinion on Drug Metabolism & Toxicology 2006, 2(1) 27-40.

Lamb DC, Kim Y, Yermalitskaya LV, Yermalitsky VN, Lepesheva GI, Kelly SL, Waterman MR, Podust LM. A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases. Structure 2006, 14(1) 51-61.

Rupasinghe S, Schuler MA, Kagawa N, Yuan H, Lei L, Zhao B, Kelly SL, Waterman MR, Lamb,DC. The cytochrome P450 gene family CYP157 does not contain EXXR in the K-helix reducing the absolute conserved P450 residues to a single cysteine. FEBS Letters 2006, 580(27) 6338-42.